Delivery Order SPE2DB20D3103-SPE2DB22FM2H0
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 40,000 units of the medication PROCRIT (40,000 units/mL vial). The $14,839.22 firm fixed-price delivery order has an ultimate completion date of October 23, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $13,206.40, is for the delivery of 40,000 units of the pharmaceutical product PROCRIT 40,000 UNITS/ML VIALML. The contract has a firm fixed price and was awarded on December 8, 2021, with a completion date of December 9, 2021. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,837.39, is for the procurement of 10,000 units of PROCRIT 10,000 units/mL vials. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,831.49 firm fixed price delivery order is for the supply of 40,000 units of the medication PROCRIT. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide...
- This federal contract award, with ID SPE2DX15D1022|SPE2DX25FUZYA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.08 fixed-price delivery order is for the supply of 10,000 units of the medication PROCRIT in 2 ml vials. The contract has an ultimate completion date of November 29, 2024. Amerisourcebergen holds a larger $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 40,000 units of PROCRIT 40,000 units/mL vials. The $2,509.46 firm fixed-price delivery order has an ultimate completion date of August 15, 2022. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The award, valued at $3,922.08, is a firm fixed price delivery order for the supply of PROCRIT 20,000 units/ml vials. The contract has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
- This federal contract award is for the delivery of PROCRIT 10,000 units/mL vials to support the Defense Logistics Agency (DLA) Troop Support Medical. The $6,388.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 1, 2022 with a completion date of March 2, 2022. The contract is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award, valued at $13,989.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 units of PROCRIT 10,000 units/mL vials, a medical product used to treat various conditions. The contract does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM2H0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,580.10, is for the delivery of 40,000 units of the medication PROCRIT 40,000 units/mL. The contract has a firm fixed price pricing type and an ultimate completion date of January 11, 2022. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is the prime contractor for this award. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 1/10/22 |